Physician profile
James Liu
NPI 1184468456
$1,119.72
in general payments reported to CMS, 2019-2025
12 companies · $810 in 2025
The $810 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $310 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $208.61 | 2024-2025 | Voquezna |
| Novo Nordisk INC | $206.79 | 2024-2025 | Ozempic |
| Glaxosmithkline, LLC. | $121.82 | 2025 | Arexvy |
| Axsome Therapeutics, INC. | $105.64 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $102.99 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $102.37 | 2025 | Rexulti |
| Amgen INC. | $96.89 | 2025 | Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $95.21 | 2025 | Caplyta |
| Verona Pharma, INC. | $20.81 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $19.80 | 2025 | Winrevair |
| Philips North America LLC | $19.75 | 2025 | Encore |
| Exact Sciences Corporation | $19.04 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.